Physician profile
Carmen Rivera
NPI 1053578195
$555.88
in general payments reported to CMS, 2019-2025
15 companies · $96.47 in 2025
The $96.47 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $34.37 · 2021: $50.32 · 2022: $153 · 2023: $23.06 · 2024: $73.03 · 2025: $96.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $133.31 | 2019-2022 | |
| Pfizer INC. | $90.63 | 2021-2025 | |
| Abbott Laboratories | $81.78 | 2021-2024 | Freestyle Libre 3 |
| Cranial Technologies, INC | $45.61 | 2022-2025 | Doc Band |
| Novartis Pharmaceuticals Corporation | $24.27 | 2022 | |
| Phadia US INC. | $23.06 | 2023 | Immunocap |
| Sanofi Pasteur INC. | $22.77 | 2025 | |
| Redhill Biopharma INC. | $21.49 | 2020 | |
| Merck Sharp & Dohme LLC | $21.02 | 2025 | Vaxneuvance, Rotateq, Enflonsia |
| Boston Scientific Corporation | $19.61 | 2022 | |
| Nalu Medical, INC. | $17.62 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.44 | 2019 | |
| Seqirus USA INC | $13.34 | 2024 | Flucelvax |
| Genentech USA, INC. | $12.88 | 2020 | |
| Lucid Diagnostics INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.